Protocol No.: D926UL00001

Title
A Phase IV, Open-Label, Single-Arm Study of Prophylaxis for Datopotamab Deruxtecan-related Stomatitis in Eligible Patients with Metastatic or Inoperable Locally Recurrent Breast Cancer or Locally Advanced or Metastatic Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer (TROPION-SWISH)
Principal Investigator
Baka, Nadia
Phase
IV
Age Group
Adult
Applicable Disease Sites
Breast Cancer
Lung Cancer
Participating Institution
Mary Babb Randolph Cancer Center
Contact
Kaitlyn Hager
Research Nurse

View on ClinicalTrials.gov